Sandu Pharmaceuticals, Inc. | Small-cap | Healthcare
₹49.98
-0.46%
| Sandu Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 671.9M
Gross Profit 350.9M 52.22%
Operating Income 20.9M 3.12%
Net Income 15.5M 2.31%

Balance Sheet Metrics

Total Assets 557.2M
Total Liabilities 137.0M
Shareholders Equity 420.2M
Debt to Equity 0.33

Cash Flow Metrics

Operating Cash Flow 5.3M
Free Cash Flow 104.0K

Revenue & Profitability Trend

Sandu Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 671.9M 672.8M 653.5M 655.0M 587.4M
Cost of Goods Sold 321.0M 337.6M 322.6M 357.4M 356.6M
Gross Profit 350.9M 335.2M 330.9M 297.6M 230.9M
Operating Expenses 214.1M 209.0M 192.9M 276.5M 126.5M
Operating Income 20.9M 17.1M 19.7M 23.4M 16.0M
Pre-tax Income 21.6M 20.7M 22.2M 23.2M 16.8M
Income Tax 6.1M 6.1M 7.0M 7.3M 5.9M
Net Income 15.5M 14.6M 15.2M 15.9M 10.9M
EPS (Diluted) - ₹1.51 ₹1.62 ₹1.87 ₹1.54

Income Statement Trend

Sandu Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 263.0M 223.0M 255.4M 236.5M 305.4M
Non-Current Assets 294.2M 301.1M 286.2M 256.4M 164.2M
Total Assets 557.2M 524.1M 541.7M 492.8M 469.6M
Liabilities
Current Liabilities 120.9M 106.4M 138.8M 118.7M 125.2M
Non-Current Liabilities 16.2M 11.8M 10.4M 9.4M 9.5M
Total Liabilities 137.0M 118.2M 149.3M 128.1M 134.7M
Equity
Total Shareholders Equity 420.2M 405.9M 392.4M 364.7M 334.9M

Balance Sheet Composition

Sandu Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 21.6M 20.7M 22.2M 23.2M 16.8M
Operating Cash Flow 5.3M 49.6M -12.2M 10.8M 64.4M
Investing Activities
Capital Expenditures -9.4M -14.3M -10.7M -8.4M -1.3M
Investing Cash Flow -3.0M -14.7M 3.8M -55.5M -57.7M
Financing Activities
Dividends Paid -7.7M -7.2M -6.6M -3.2M -
Financing Cash Flow -7.7M -13.9M 13.2M 10.2M 1.9M
Free Cash Flow 104.0K -6.7M -8.5M 1.1M 74.6M

Cash Flow Trend

Sandu Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 31.49
Price to Book 1.15
Price to Sales 0.72

Profitability Ratios

Profit Margin 2.31%
Operating Margin 2.13%
Return on Equity 3.76%
Return on Assets 2.42%

Financial Health

Current Ratio 2.18
Debt to Equity 1.14
Beta 0.12

Per Share Data

EPS (TTM) ₹1.60
Book Value per Share ₹43.77
Revenue per Share ₹69.28

Financial data is updated regularly. All figures are in the company's reporting currency.